Characterization of 5-HT receptors on human pulmonary artery and vein: functional and binding studies

British Journal of Pharmacology
J CortijoE J Morcillo

Abstract

1. This study aimed to investigate the 5-hydroxytryptamine (5-HT) receptors mediating contraction of ring preparations isolated from human pulmonary arteries and veins. In functional studies, the responses to 5-HT, sumatriptan, ergotamine, serotonin-O-carboxymethyl-glycyl-tyrosinamide (SCMGT), alpha-methyl 5-HT (alpha-Me) and 2-methyl 5-HT (2-Me) were studied with WAY100635, GR127935, ritanserin, zacopride and SB204070 as antagonists. 2. All agonists produced concentration-dependent contractions of human pulmonary artery and vein preparations. The order of potency (-log ECS0 values) was ergotamine (6.88) > 5-HT (6.41) > or = SCMGT (6.20) = sumatriptan (6.19) > or = alpha-Me (6.04) in the artery, and ergotamine (7.84) > 5-HT (6.96) > sumatriptan (6.60) = alpha-Me (6.56) > SCMGT (6.09) in the vein. The potency of each agonist, except for SCMGT, was greater in vein than in artery preparations. Contractile responses to 5-HT were similar in intact and endothelium-denuded preparations but responses to sumatriptan were enhanced in artery rings without endothelium. 3. GR127935 (1 nM to 0.5 microM) produced an unsurmountable antagonism of the response to 5-HT, sumatriptan, ergotamine and SCMGT. Ritanserin (1 nM to 1 microM) also reduced...Continue Reading

References

Sep 4, 1992·European Journal of Pharmacology·M BodelssonB Arneklo-Nobin
Feb 1, 1989·British Journal of Pharmacology·A A ParsonsP P Humphrey
Apr 1, 1988·The Journal of Pharmacy and Pharmacology·W W SmithL Lambert
Jan 1, 1988·Journal of Receptor Research·D Hoyer
Jul 1, 1987·British Journal of Pharmacology·B T Altura, B M Altura
Sep 1, 1986·British Journal of Pharmacology·J R Docherty, L Hyland
Jul 1, 1984·Naunyn-Schmiedeberg's Archives of Pharmacology·M Frenken, A J Kaumann
Sep 1, 1995·The American Journal of Medicine·P HervéL Drouet
Jun 26, 1993·Lancet·F C Rose
Jul 1, 1993·Trends in Pharmacological Sciences·D Hoyer, H W Boddeke
May 24, 1994·Proceedings of the National Academy of Sciences of the United States of America·K IshikawaT Nagase
Dec 1, 1993·British Heart Journal·F BrenotG Simonneau
Aug 1, 1993·British Journal of Pharmacology·H P NowakF D Yocca
Aug 1, 1995·British Journal of Pharmacology·J L OrtizC Brink
Nov 1, 1995·British Journal of Pharmacology·B SarriáC Advenier
Sep 1, 1996·British Journal of Pharmacology·M R MacLeanI Morecroft

❮ Previous
Next ❯

Citations

Dec 18, 2008·Experimental and Clinical Psychopharmacology·Richard B RothmanMichael H Baumann
Apr 10, 2010·The Journal of Pharmacology and Experimental Therapeutics·A Elizabeth LinderStephanie W Watts
Nov 11, 2008·Annals of the New York Academy of Sciences·Richard B RothmanMichael H Baumann
Dec 7, 2010·Pharmacology & Therapeutics·Kayi Y ChanAntoinette Maassenvandenbrink
Sep 6, 2008·Progress in Brain Research·Richard B RothmanMichael H Baumann
Feb 12, 2002·The American Journal of Medicine·Dara G Jamieson
Mar 20, 2004·Cephalalgia : an International Journal of Headache·D W Dodick
Oct 6, 2009·Reproductive Sciences·António José Santos-SilvaIgnacio Verde
Dec 12, 2017·Expert Opinion on Drug Metabolism & Toxicology·Abimael González-HernándezCarlos M Villalón
Oct 24, 2018·The Journal of Experimental Biology·Daniel García-PárragaAndreas Fahlman
May 25, 2007·Fundamental & Clinical Pharmacology·Sónia A SilvaCarlos A Fontes Ribeiro
Oct 30, 2003·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Enzo Nisoli, Michele O Carruba
May 20, 2004·Headache·David W DodickStephen Silberstein
Apr 29, 2006·The Journal of Pharmacology and Experimental Therapeutics·Dorota ZolkowskaMichael H Baumann
Jan 28, 2003·Journal of Cardiovascular Pharmacology·Husamettin GulDervis Sen
Feb 27, 2003·Journal of Cardiovascular Pharmacology·Hakima MechichePhilippe Devillier
Jul 18, 2001·Journal of Applied Physiology·S BelohlávkováV Hampl
May 19, 2004·Headache·David DodickUNKNOWN Triptan Cardiovascular Safety Expert Panel
Sep 10, 2016·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Lidan NongJianxiu Cui
Dec 12, 2001·Cephalalgia : an International Journal of Headache·J BouJ M Palacios
Dec 14, 2017·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Jonathan Jia Yuan Ong, Milena De Felice

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.